Estradiol Patch
Product Images NDC 68382-323

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 68382-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Estradiol Transdermal System, 14 Mcg/day (D2877798 77ea 4f75 B632 9b16be09042f 01)

FDA Label Image

Estradiol Transdermal System, 14 Mcg/ Day (D2877798 77ea 4f75 B632 9b16be09042f 02)

FDA Label Image

Estradiol Transdermal System, 14 Mcg/day (D2877798 77ea 4f75 B632 9b16be09042f 03)

FDA Label Image

Pouch (D2877798 77ea 4f75 B632 9b16be09042f 04)

Pouch (D2877798 77ea 4f75 B632 9b16be09042f 04)
The text provides information about a medication called Estradiol Transdermal System, USP. The medication is available in the form of a transdermal system that needs to be applied once a week. Each system contains 0.982 mg of estradiol USP, which provides a daily dose of 0.014 mg of estradiol. The transdermal system includes several inactive components such as acrylic adhesive, colloidal silicon dioxide, ethyl oleate, glyceryl monolaurate, isopropyl myristate, povidone, and polyethylene backing. The packaging includes one transdermal system. The medication is intended for transdermal use only and is designated for prescription use only (Rx only). Unfortunately, the description does not include any further information due to the limitations of the text.*
FDA Label Image

Figure B (D2877798 77ea 4f75 B632 9b16be09042f 05)

Figure B (D2877798 77ea 4f75 B632 9b16be09042f 05)
The text is describing a medication called "Estradiol Transdermal System, USP". It states that each transdermal system contains 0.014 mg of estradiol USP, and it should be applied once per week. The inactive components of the system include acrylic adhesive, colloidal silicon dioxide, ethyl oleate, glyceryl monolaurate, isopropyl myristate, povidone, and polyethylene backing. The product is for transdermal use only and the package contains one transdermal system. Unfortunately, the image or figure mentioned in the text is not available for evaluation.*
FDA Label Image

Figure C And D (D2877798 77ea 4f75 B632 9b16be09042f 06)

FDA Label Image

Figure E And F (D2877798 77ea 4f75 B632 9b16be09042f 07)

FDA Label Image

Figure G (D2877798 77ea 4f75 B632 9b16be09042f 08)

FDA Label Image

Estradiol Transdermal System, Usp 0.014mg/day (D2877798 77ea 4f75 B632 9b16be09042f 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.